Loading…
Loading…
BCTXZ is a hybrid capital security, not common stock.
This listing is a capital note, preference share, or similar instrument associated with BriaCell Therapeutics Corp. Warrant. Data providers report company-level figures against it, so fundamentals, valuation multiples, and dividend history on this page describe the issuing company — not this instrument — and its market capitalization cannot be computed reliably, so it is not shown. The quoted price is the instrument's own.
| AIMD | Ainos, Inc. | $1.42 | $10.5M |
| MLEC | Moolec Science S.A. | $6.86 | $5.0M |
| ELAB | PMGC Holdings Inc. | $5.83 | $2.6M |
| ATXI | Avenue Therapeutics, Inc. | $0.58 | $1.9M |
| NCEL | NewcelX Ltd. | $3.42 | $1.5M |
| DRMA | Dermata Therapeutics, Inc. | $1.46 | $995.1K |
| XRTX | XORTX Therapeutics Inc. | $2.44 | $679.5K |
| VRAX | Virax Biolabs Group Limited | $2.94 | $548.7K |
| NKGN | NKGen Biotech, Inc. | $0.00 | $274.3K |
| WINT | Windtree Therapeutics, Inc. | $0.00 | $3.4K |